KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Liabilities and Shareholders Equity (2016 - 2026)

Johnson & Johnson's Liabilities and Shareholders Equity history spans 18 years, with the latest figure at $200.9 billion for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 3.73% to $200.9 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $786.3 billion, a 7.25% increase, with the full-year FY2025 number at $199.2 billion, up 10.61% from a year prior.
  • Liabilities and Shareholders Equity hit $200.9 billion in Q1 2026 for Johnson & Johnson, up from $199.2 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for JNJ hit a ceiling of $200.9 billion in Q1 2026 and a floor of $166.1 billion in Q4 2023.
  • Historically, Liabilities and Shareholders Equity has averaged $184.1 billion across 5 years, with a median of $181.6 billion in 2022.
  • Biggest five-year swings in Liabilities and Shareholders Equity: fell 12.25% in 2024 and later rose 12.62% in 2025.
  • Tracing JNJ's Liabilities and Shareholders Equity over 5 years: stood at $175.1 billion in 2022, then decreased by 4.32% to $167.6 billion in 2023, then increased by 7.49% to $180.1 billion in 2024, then increased by 10.61% to $199.2 billion in 2025, then rose by 0.85% to $200.9 billion in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for JNJ at $200.9 billion in Q1 2026, $199.2 billion in Q4 2025, and $192.8 billion in Q3 2025.